retatrutide type 2 diabetes trial results 2024 produces up to 30.3% weight loss in Phase 3 This data from Phase 3

Frequency Once weekly, subcutaneous

Start your intake Why Weight Loss Plateaus Happen on GLP-1 Therapy The human body adapts to calorie reduction through a process called metabolic adaptation

When combined with lifestyle guidance and balanced nutrition, the medication helps patients maintain steady progress toward their health and weight-management goals

Even at moderate doses , retatrutide outperformed existing incretin mimetics, with 8 mg weekly doses yielding reductions exceeding 20%

But I got through it, and by week 9, I felt almost normal again

When you know exactly what dose you are taking and exactly when you are taking it, correlating those numbers with your side effect and energy data becomes straightforward